Pages that link to "Q38536898"
Jump to navigation
Jump to search
The following pages link to Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children (Q38536898):
Displaying 4 items.
- Atypical antipsychotics for disruptive behaviour disorders in children and youths (Q38632745) (← links)
- Lurasidone for the treatment of irritability and anger in autism spectrum disorders (Q38689883) (← links)
- Executive Function Deficits in Seriously Ill Children-Emerging Challenges and Possibilities for Clinical Care. (Q55028716) (← links)
- The effects of antipsychotic medications on microbiome and weight gain in children and adolescents. (Q64939436) (← links)